Recent Finacing
Recent Raise
Aprinoia Therapeutics is a Taipei-based biopharma developing tau PET imaging tracers and therapeutics for Alzheimer's, non-AD tauopathies, Lewy body dementia and Parkinson's, with operations in Taiwan, China and Japan.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at APRINOIA Therapeutics.